Our services include a series of aspects of a pharmaceutical product ranging from the strategic planning phase, market dimension, patient forecast models, business models, in-depth knowledge of a disease, of the competition, patients, specific target and of the ACCESS MARKET and HEALTH ECONOMICS with specialization in the government sector.

We are divided into two large BUSINESS UNITS: DISEASE MANAGMENT DIVISION and HEALTH ECONOMICS & OUTCOME RESEARCH DIVISION. Each business unit is responsible for specific services:
 

A)  DISEASE MANAGEMENT DIVISION

• Epimodel
• Introscope
• Meta-análisis de estudios clínicos
• Target especializado
• Licensing estratégico
• Modelos en sistema de salud
• Modelos analíticos a partir de bases de datos en salud
• Informática médica

B) HEALTH ECONOMICS AND OUTCOME RESEARCH DIVISION

• Cost of desease
• Burden of a disease
• Pharmacoeconomics studies
• Econometric models
• Evaluation of the impact of healthcare programs and procedures
• Shared risk calculation